Coagulation Analyzers & Reagents Market Worth $7.9 Billion by 2024: Grand View Research, Inc.

Wednesday, November 30, 2016 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, November 30, 2016 /PRNewswire/ --

The global coagulation analyzers/reagents market is expected

to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth
of the market. Automation is the key development that has occurred in recent years.

     (Logo: )

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

  • Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
  • Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
  • Automatic reflex testing, repeat testing, and redilution

Browse full research report with TOC on "Coagulation Analyzer Market Analysis By Product, By Technology (Mechanical, Electrochemical) By Test Types (APTT, D-Dimer, Fibrinogen, PT) By End Use (Hospitals, Research Institutes) & Segment Forecasts, 2013 - 2024" at:

Further key findings from the study suggest: 

  • Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
  • Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
  • Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
  • Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
  • The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
  • Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
  • For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.

Browse related reports by Grand View Research: 

  • Glucose Monitoring Device Market -
  • Infectious Vaccines Market -
  • Neurovascular Intervention Devices Market -
  • X-Ray Detectors Market -

Grand View Research has segmented the global Coagulation Analyzers & Reagents market on the basis of product, technology, test type, end-use and region. 

  • Product Outlook (Revenue, USD Million, 2013 - 2024) 
    • Analyzers
      • Clinical Laboratory Analyzers
      • Point of Care Analyzers   
    • Consumables
      • Reagents
      • Stains
  • Technology Outlook (Revenue, USD Million, 2013 - 2024) 
    • Mechanical
    • Electrochemical
    • Optical
      • Photo optical/Chromogenic/Immuno
      • Others/Nephelometric
    • Others
  • Test Type Outlook (Revenue, USD Million, 2013 - 2024) 
    • APTT
    • D-Dimer
    • Fibrinogen
    • Prothrombin
    • Others
  • End-Use Outlook (Revenue, USD Million, 2013 - 2024) 
    • Hospitals
    • Research Institutes
    • Diagnostic Centers
    • Others
  • Regional Outlook (Revenue, USD Million, 2013 - 2024) 
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa

Access research insight:

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs -

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]


SOURCE Grand View Research, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store